Signal Genetics FY14 results

• Signal Genetics (SGNL +1.5%) FY14 results: Revenues: $4.3M (+0.1%); COGS: $3.2M (+14.3%); R&D Expense: $0.3M (+50.0%); SG&A: $7.8M (+333.3%); Operating Loss ($6.9M) (-999%); Net Loss: ($7.9M) (-229.2%); Loss Per Share: ($3.50) (+71.4%); Quick Assets: $5.2M (+999%).
• No guidance given.